Progresive Lifesciences Private Limited
About Progresive Lifesciences Private Limited
Data last updated:
Progresive Lifesciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2005PTC438097. Its GSTIN is 05AAECP0409P1ZD (Uttarakhand).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹31.2 Lakh. It is led by directors Rajesh Kumar Hariharprasad Tiwari and Menpal Singh.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No 14 Block – H Pkt 5, Sector 16 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.81 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Cr (net margin 3.5%) and EBITDA of ₹2.47 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 26% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹5.01 Cr on record. Court records list 1 case involving the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No 14 Block – H Pkt 5, Sector 16 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Progresive Lifesciences Private Limited FY 2024 filings available
Progresive Lifesciences Private Limited reported revenue of ₹37.81 Cr (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Progresive Lifesciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 28% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Progresive Lifesciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹37.81 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.47 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.33 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Progresive Lifesciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Progresive Lifesciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Progresive Lifesciences Private Limited
Progresive Lifesciences Private Limited is audited by ANKIT JAIN for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANKIT JAIN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Progresive Lifesciences Private Limited
Progresive Lifesciences has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Hariharprasad Tiwari Also directs: Antex Pharma Private Limited, Alexza Labs Private Limited | Director | 27 Sep 2024 | 2 Years 0 Months | Current |
| Menpal Singh | Director | 15 Jul 2022 | 4 Years 2 Months | Current |
Ownership and Shareholding of Progresive Lifesciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Progresive Lifesciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2022 | Axis Bank Limited | ₹2 Cr | Open |
| 21 Jan 2013 | Hdfc Bank Limited | ₹2.11 Cr | Satisfied |
| 29 Nov 2007 | Bank of India Muradpur Chauhatta Branch | ₹2.9 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Progresive Lifesciences Private Limited
Progresive Lifesciences Private Limited has 1 court case on record: 1 where it is another party. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Company is another party | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Progresive Lifesciences Private Limited
Progresive Lifesciences Private Limited has a workforce of 24 employees as of Nov 20, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Progresive Lifesciences Private Limited
Progresive Lifesciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230DL2005PTC438097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230DL2005PTC438097 | Current |
| U24230BR2005PTC011361 | Previous |
| U24231BR2005PTC011361 | Previous |
Recent Activity on Progresive Lifesciences Private Limited
Progresive Lifesciences Private Limited has 14 board changes on record since 2007: 2 appointments and 12 cessations. The latest: Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 27 Sep 2024.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Progresive Lifesciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Progresive Lifesciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Progresive Lifesciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Progresive Lifesciences Private Limited
Progresive Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECP0409P1ZD | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Progresive Lifesciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Progresive Lifesciences Private Limited
Progresive Lifesciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 May 2005 (21+ years old) and is registered under CIN U24230DL2005PTC438097.
Progresive Lifesciences reported revenue of ₹37.81 Cr for FY 2024 (up 28% YoY).
Progresive Lifesciences has 2 current directors:
- Rajesh Kumar Hariharprasad Tiwari - Director
- Menpal Singh - Director
Progresive Lifesciences reported a net profit of ₹1.33 Cr (net margin 3.5%) and EBITDA of ₹2.47 Cr (EBITDA margin 6.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Progresive Lifesciences is 35% over three years and 26% over five years. In the latest year (FY 2024) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Progresive Lifesciences is 05AAECP0409P1ZD, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Progresive Lifesciences is U24230DL2005PTC438097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Progresive Lifesciences has 1 court case on record.
Progresive Lifesciences was incorporated on 20 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 27 Sep 2024. Amardeep Bansal ceased to be Managing Director on 18 May 2023. Menpal Singh was appointed as Director on 15 Jul 2022. Progresive Lifesciences has 14 board changes on record in total.